CVS Health (CVS) stock in focus as the company raises 2025 financial guidance, but projects 2026 revenue below consensus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback